Abiopharma

New Form 144 - Jade Biosciences, Inc. Filed: 2025-06-24 AccNo: 0001961863-25-000079 Size: 6 KB

New Form S-3 - Bone Biologics Corp Filed: 2025-06-24 AccNo: 0001641172-25-016302 Size: 757 KB

New Form 144 - UNITED THERAPEUTICS Corp Filed: 2025-06-24 AccNo: 0001950047-25-004593 Size: 4 KB

New Form SCHEDULE 13D - NLS Pharmaceutics Ltd. Filed: 2025-06-24 AccNo: 0001213900-25-057281 Size: 69 KB

New Form 4 - Tectonic Therapeutic, Inc. Filed: 2025-06-24 AccNo: 0001415889-25-018106 Size: 6 KB

New Form 4 - CORE MOLDING TECHNOLOGIES INC Filed: 2025-06-24 AccNo: 0001026655-25-000063 Size: 4 KB

New Form 8-K - INDIVIOR PLC Filed: 2025-06-24 AccNo: 0001625297-25-000042 Size: 329 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - Perimeter Solutions, Inc. Filed: 2025-06-24 AccNo: 0001880319-25-000090 Size: 4 KB

New Form 6-K - CureVac N.V. Filed: 2025-06-24 AccNo: 0001104659-25-062143 Size: 31 KB

New Form 4 - Perimeter Solutions, Inc. Filed: 2025-06-24 AccNo: 0001880319-25-000089 Size: 4 KB

Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease

New Form 4 - Perimeter Solutions, Inc. Filed: 2025-06-24 AccNo: 0001880319-25-000088 Size: 4 KB

New Form 4 - Perimeter Solutions, Inc. Filed: 2025-06-24 AccNo: 0001880319-25-000087 Size: 4 KB

New Form 4 - Perimeter Solutions, Inc. Filed: 2025-06-24 AccNo: 0001880319-25-000086 Size: 4 KB

New Form 4 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-06-24 AccNo: 0001628280-25-032863 Size: 7 KB